EPO Patents = 4

Forward Citations = 1

Loading Chart...

6 inventors (with patents filed for the assignee):

Duncan Alexander Hay (6 out of 9 patents)

Thomas Beauregard Schofield (6 out of 8 patents)

Naomi Went (5 out of 8 patents)

4. Jonathan David Hargrave (4 out of 9 patents)

5. Clive McCarthy (4 out of 24 patents)

6. Clive Mccarthy (2 out of 10 patents)

6 patents: Sort by Forward Citations

1. 12371436 - Substituted benzodiazoliums as ENaC inhibitors (2025-07-29),

2. 12037336 - Compounds with activity as inhibitors of the epithelial sodium channel (ENaC) (2024-07-16),

3. 11739094 - Substituted benzodiazoliums as ENaC inhibitors (2023-08-29),

4. 11370778 - Bis(pentahydroxyhexyl)amino substituted 2-{[(3-amino-pyrazin-2-yl)formamido]methyl}-1H-1,3-benzodiazol-3-ium derivatives as ENaC inhibitors for treating respiratory diseases (2022-06-28),

5. 10941149 - Substituted benzodiazoliums as ENaC inhibitors (2021-03-09),

6. 10759785 - Compounds (2020-09-01),

Enterprise Therapeutics Limited is a UK-based biotechnology company focused on developing novel therapies for respiratory diseases. Their innovative approach targets the underlying mechanisms of disease to provide improved treatments for patients. With a strong emphasis on research and development, Enterprise Therapeutics is dedicated to making a meaningful impact on the lives of those affected by respiratory conditions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 20 2026

6 Patents

#1 in Falmer

#2,630 in United Kingdom

Falmer, United Kingdom

Enterprise Therapeutics Limited